DALLAS -- Contrary to government claims, side effects happen more often with Crestor, a cholesterol-lowering drug that consumer advocates tried to get off the market earlier this year, a new analysis ...

Statins rank among the most prescribed medications worldwide, with millions taking these cholesterol-lowering drugs daily to reduce their cardiovascular risk. While these medications effectively lower ...

A. Gastroparesis means stomach paralysis. The drug semaglutide (Ozempic, Rybelsus, Wegovy) can cause delayed stomach emptying ...

A statin can be a lifesaver if you're at risk of heart disease, but some people who take the cholesterol-lowering drugs -- up to 20 percent, by some estimates -- have to stop because of muscle pain, ...

WASHINGTON (Reuters) - U.S. regulators see benefits to using an AstraZeneca Plc cholesterol drug in a vast new group of patients but will ask outside advisers to probe various safety issues, documents ...

Drugmaker AstraZeneca PLC’s big gamble, an attempt to prove its top-selling drug works better than rival cholesterol blockbuster Lipitor, appears to have backfired. A study meant to show AstraZeneca’s ...

What is rosuvastatin Crestor, Ezallor Sprinkle? Rosuvastatin is used together with diet to lower blood levels of bad cholesterol low-density lipoprotein, or LDL, to increase levels of good cholesterol ...

These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.

A new way of determining heart disease risk may result in millions fewer people getting prescriptions for statins, according to new research. Heart doctors warned, however, that more information is ...

Plan can save enrollees an estimated $230-$300 in 2011 2 on two popular cholesterol-lowering drugs through a network of 64,000 pharmacies nationwide TexanPlus HMO provides medical and hospital ...

DALLAS - Contrary to government claims, side effects happen more often with Crestor, a cholesterol-lowering drug that consumer advocates tried to get off the market earlier this year, a new analysis ...